DexCom (DXCM) Misses Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.07 -4.69%
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +27.1%
Financial Fact:
Development grant and other revenue: 0
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.24), $0.12 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $137.3 million versus the consensus estimate of $132.59 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Accenture downgraded by TD Cowen on AI concerns
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
